120 related articles for article (PubMed ID: 8548883)
1. Isozyme-specific glutathione S-transferase inhibitors potentiate drug sensitivity in cultured human tumor cell lines.
Morgan AS; Ciaccio PJ; Tew KD; Kauvar LM
Cancer Chemother Pharmacol; 1996; 37(4):363-70. PubMed ID: 8548883
[TBL] [Abstract][Full Text] [Related]
2. The human glutathione transferase P1-1 specific inhibitor TER 117 designed for overcoming cytostatic-drug resistance is also a strong inhibitor of glyoxalase I.
Johansson AS; Ridderström M; Mannervik B
Mol Pharmacol; 2000 Mar; 57(3):619-24. PubMed ID: 10692504
[TBL] [Abstract][Full Text] [Related]
3. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.
Geroni C; Marchini S; Cozzi P; Galliera E; Ragg E; Colombo T; Battaglia R; Howard M; D'Incalci M; Broggini M
Cancer Res; 2002 Apr; 62(8):2332-6. PubMed ID: 11956092
[TBL] [Abstract][Full Text] [Related]
4. Conjugation of chlorambucil with GSH by GST purified from human colon adenocarcinoma cells and its inhibition by plant polyphenols.
Zhang K; Wong KP; Chow P
Life Sci; 2003 Apr; 72(23):2629-40. PubMed ID: 12672508
[TBL] [Abstract][Full Text] [Related]
5. Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells.
Chen G; Waxman DJ
Biochem Pharmacol; 1994 Mar; 47(6):1079-87. PubMed ID: 8147907
[TBL] [Abstract][Full Text] [Related]
6. Lentinan enhances sensitivity of mouse colon 26 tumor to cis-diamminedichloroplatinum (II) and decreases glutathione transferase expression.
Murata T; Hatayama I; Kakizaki I; Satoh K; Sato K; Tsuchida S
Jpn J Cancer Res; 1996 Nov; 87(11):1171-8. PubMed ID: 9045947
[TBL] [Abstract][Full Text] [Related]
7. Potent isozyme-selective inhibition of human glutathione S-transferase A1-1 by a novel glutathione S-conjugate.
Cacciatore I; Caccuri AM; Cocco A; De Maria F; Di Stefano A; Luisi G; Pinnen F; Ricci G; Sozio P; Turella P
Amino Acids; 2005 Nov; 29(3):255-61. PubMed ID: 16082503
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and evaluation of latent alkylating agents activated by glutathione S-transferase.
Satyam A; Hocker MD; Kane-Maguire KA; Morgan AS; Villar HO; Lyttle MH
J Med Chem; 1996 Apr; 39(8):1736-47. PubMed ID: 8648613
[TBL] [Abstract][Full Text] [Related]
9. The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines.
Mistry P; Kelland LR; Abel G; Sidhar S; Harrap KR
Br J Cancer; 1991 Aug; 64(2):215-20. PubMed ID: 1892748
[TBL] [Abstract][Full Text] [Related]
10. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
Xu BH; Gupta V; Singh SV
Arch Biochem Biophys; 1994 Jan; 308(1):164-70. PubMed ID: 8311448
[TBL] [Abstract][Full Text] [Related]
11. Modulation of mitomycin C resistance by glutathione transferase inhibitor ethacrynic acid.
Singh SV; Xu BH; Maurya AK; Mian AM
Biochim Biophys Acta; 1992 Nov; 1137(3):257-63. PubMed ID: 1445927
[TBL] [Abstract][Full Text] [Related]
12. Role of glutathione and glutathione S-transferase in chlorambucil resistance.
Yang WZ; Begleiter A; Johnston JB; Israels LG; Mowat MR
Mol Pharmacol; 1992 Apr; 41(4):625-30. PubMed ID: 1569917
[TBL] [Abstract][Full Text] [Related]
13. Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione-S-transferase activity.
Alaoui-Jamali MA; Panasci L; Centurioni GM; Schecter R; Lehnert S; Batist G
Cancer Chemother Pharmacol; 1992; 30(5):341-7. PubMed ID: 1505071
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis and cell cycle arrest in mouse colon 26 cells by benastatin A.
Kakizaki I; Ookawa K; Ishikawa T; Hayakari M; Aoyagi T; Tsuchida S
Jpn J Cancer Res; 2000 Nov; 91(11):1161-8. PubMed ID: 11092982
[TBL] [Abstract][Full Text] [Related]
15. Hepsulfam sensitivity in human breast cancer cell lines: the role of glutathione and glutathione S-transferase in resistance.
Armstrong DK; Gordon GB; Hilton J; Streeper RT; Colvin OM; Davidson NE
Cancer Res; 1992 Mar; 52(6):1416-21. PubMed ID: 1540950
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a chlorambucil-resistant human ovarian carcinoma cell line overexpressing glutathione S-transferase mu.
Horton JK; Roy G; Piper JT; Van Houten B; Awasthi YC; Mitra S; Alaoui-Jamali MA; Boldogh I; Singhal SS
Biochem Pharmacol; 1999 Aug; 58(4):693-702. PubMed ID: 10413308
[TBL] [Abstract][Full Text] [Related]
17. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
Wang W; Liu G; Zheng J
Eur J Pharmacol; 2007 Jul; 568(1-3):61-7. PubMed ID: 17509556
[TBL] [Abstract][Full Text] [Related]
18. Glutathione-dependent biotransformation of the alkylating drug thiotepa and transport of its metabolite monoglutathionylthiotepa in human MCF-7 breast cancer cells.
Cnubben NH; Rommens AJ; Oudshoorn MJ; Van Bladeren PJ
Cancer Res; 1998 Oct; 58(20):4616-23. PubMed ID: 9788613
[TBL] [Abstract][Full Text] [Related]
19. Modulation of detoxification gene expression in human colon HT29 cells by glutathione-S-transferase inhibitors.
Ciaccio PJ; Shen H; Jaiswal AK; Lyttle MH; Tew KD
Mol Pharmacol; 1995 Oct; 48(4):639-47. PubMed ID: 7476889
[TBL] [Abstract][Full Text] [Related]
20. Isozyme specificity of novel glutathione-S-transferase inhibitors.
Flatgaard JE; Bauer KE; Kauvar LM
Cancer Chemother Pharmacol; 1993; 33(1):63-70. PubMed ID: 8269591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
